FDA Appoints Michele Mital as Acting CTP Director

Apr.02.2022
FDA Appoints Michele Mital as Acting CTP Director
Michele Mital appointed acting director of FDA's tobacco products center as Mitch Zeller retires in April.

According to foreign media reports, when Mitch Zeller retired in April, the FDA's Center for Tobacco Products appointed current CTP Deputy Director Michele Mital as acting director. The agency is currently searching for a permanent director.


On March 31, 2022, FDA Tracker reported on this news for the first time in a tweet, and received confirmation from Filter reporter Alex Norcia after speaking with FDA officials. An official announcement has not yet been released.


According to a paid report by ECig Intelligence on March 25th, Mital is the most likely candidate to take on the permanent position, although other applications are still under review. ECig Intelligence suggests that with her 25-year history at the organization, she is considered as "safe hands.


Whoever is appointed as a permanent director must receive approval from newly-appointed FDA commissioner Robert Califf and Department of Health and Human Services secretary Xavier Becerra, both of whom are skeptical and hostile towards e-cigarettes. In recent years, both have advocated for a complete ban of flavored products.


Mital joined the FDA in 1996 and has served in multiple positions, including in the legislative office. Since the establishment of CTP in 2009, Mital has worked there in various capacities, and was appointed Deputy Director in 2018.


Mitch Zeller has been serving as the director of the Center for Tobacco Products (CTP) since 2013, making him the second person to hold the position since the CTP was established in 2009. He has led the organization as it granted itself regulatory authority over electronic cigarettes under the estimated rules of 2016, and oversaw the implementation of a chaotic pre-market review process.


After a year-long review of Pre-Market Tobacco Applications (PMTAs), the agency issued millions of standardized marketing denial orders (MDOs) to hundreds of small e-cigarette manufacturers, effectively eliminating over 99% of the legal e-cigarette market. The FDA is now facing dozens of legal challenges from independent e-cigarette manufacturers, and has been forced to rescind some MDOs while others are pending in federal court.


Since the submission deadline for Pre-Market Tobacco Product Applications (PMTA) in September 2020, the agency has only authorized three types of electronic cigarette devices.


(Source: Vaping360)


The Deputy Director of the Center for Tobacco Products (CTP) will act as the interim Director when the current Director, Zeller, retires. This move was announced in the vaping industry news platform, Vaping360.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

JTI appoints Olesja Flores as General Manager for Global Travel Retail
JTI appoints Olesja Flores as General Manager for Global Travel Retail
Japan Tobacco International (JTI) has appointed veteran executive Olesja Flores as General Manager, Global Travel Retail. Flores, who has spent more than 25 years at JTI and most recently served as General Manager for the Swiss market, will be based in Dubai and oversee the company’s global travel retail business.
Jan.23 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
British American Tobacco said 2026 will mark a return to its mid-term growth algorithm, but CEO Tadeu Marroco stressed that deliverywill depend heavily on enforcement against illicit vapour products in the United States. Speaking at the FY2025 results call, he positioned Modern Oral as the company’s primary structural growth engine, reframed accelerating cigarette declines through “poly-usage,” and reinforced capital discipline with an expanded share buyback plan.
Feb.12
Tennessee’s “Tobacco Product Retail Licensing Act” Would Require New Licenses for Tobacco and Vapes
Tennessee’s “Tobacco Product Retail Licensing Act” Would Require New Licenses for Tobacco and Vapes
A newly introduced Tennessee bill, S.B. 2086, would create a statewide tobacco product retail licensing system, move oversight to the Tennessee Alcohol Commission, and impose fees and escalating penalties. The proposal also requires all tobacco product sales to occur as in-person, over-the-counter transactions at licensed locations—effectively banning direct-to-consumer shipping of cigars and potentially restricting curbside or phone-order pickup models.
Jan.28 by 2FIRSTS.ai
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT reported record FY2025 revenue and adjusted operating profit, supported by combustible resilience and accelerating reduced-risk product growth. Heated tobacco volumes surged, led by Ploom. The group confirmed a major three-year RRP investment plan and projected further growth in 2026.
Feb.12
Product | Claiming “U.S.-Made E-Liquid” and “80,000 Puffs,” VOOPOO Launches NAVI×Cyph 80K
Product | Claiming “U.S.-Made E-Liquid” and “80,000 Puffs,” VOOPOO Launches NAVI×Cyph 80K
VOOPOO’s website shows the company has introduced the NAVI×Cyph Kit 80K, an open-system, refillable vaping kit claimed to deliver up to 80,000 puffs. The device features a 1,500mAh battery with USB Type-C charging and comes in 12 flavors. A promotional image posted on VOOPOO’s official Instagram account includes the phrase “E-LIQUID BUILT IN THE USA.”
Feb.10 by 2FIRSTS.ai